About Lymphoma | Advocacy | Art | CAM | Clinical trials | Doctors - Experts - Centers | Guidelines at Diagnosis | News
Risk Factors | Side Effects | Statistics | Support | Symptoms | Tests | Treatments | Types of Lymphoma

Search Site   |  How to Help!

Patients Against Lymphoma

 

About Lymphoma

Last update: 09/23/2014

Menu A to Z 

Evidenced-based topics developed in response to patient questions
 

A | B | C | D | E | F | G | H | I | J | K | L | M | NO | P | Q | R | S | T | U | V | W | X | Y | Z

Advancing the routine and informed consideration of clinical trials

What is Lymphoma
 

bullet

Lymphoma overview
 

bullet

The Lymphatic System
 

bullet

Types of Lymphomas 

& Classifications 
 

bullet

Lymphoma Simplified - how it begins 
 

bullet

What is Lymphoma -
a detailed description

About Cancer  

Lymphoma is a cancer affecting immune cells called lymphocytes
 
About Lymphoma - General
 
 
Where Lymphoma Develops

Type and Developmental Stages  determines lymphoma type

Characteristics of lymphoma
   Cell type  and   Histology  
   Grading  (counting centroblasts)
   Staging  (where and how widespread)

WHO & REAL classifications (two ways to evaluate and group types of NHL)

Host/tumor interactions - the microenvironment

bullet The Big Picture:  Battling the Hematological Malignancies: 
The 200 Years' War theoncologist | PDF

 

 

Background Topics
 

bullet
Terms to help in your understanding:

Diagnostic terms

General and Immunity terms  

Response and remission terms

bullet

Antibiotics for Lymphoma treatment - indications

bullet

Biology and Immunity Resources *

bullet
Bone Marrow Involvement  
bullet
Diagnosis and Pathology
bullet

Expert Interviews

bullet

Genes and Cancer: an overview

bullet

Getting a Second Pathology Evaluation

bullet
Grades and Cell Types  
bullet
Immune Suppression and Lymphoma
bullet
Leukemic (blastoid) Phase  
bullet
Lymphatic System
bullet

Metastasis of Lymphoma?

bullet
Microenvironment  
bullet
Monitoring indolent lymphomas | DLBCL
bullet

Initial Assessment, workups and Surveillance

bullet

Paraneoplastic Syndromes (Mayo Clinic 2010)

bullet
Prognostic Indicators and Biomarkers  
bullet
Prognostic and Need-to-Treat Indications
Prognostic
IPI | FLIPI / FLIPI-2
MIPI | CLL/SLL
Need to Treat
GELF | NCCN

 

 

bullet

Relapse - considerations

bullet

Response, Remission ... Terminology

bullet

Risk Factors for acquiring lymphoma

bullet

Spontaneous Regressions

bullet

Staging

bullet

Statistics - survival, incidence, prevalence, trends 

bullet

Symptoms of Lymphoma

bullet

Testimonials - the problem with

bullet

Transformation, about

bullet

Treatment Goals, Terms, Outcomes, and  Types of Interventions

bullet

Tumor Basics

bullet

Watchful Waiting

Resources
 

bullet

Expert Review Articles and Interviews

 Treatment-Related 
  

bullet

Agents that target disease pathways

bullet

Treatment Decisions

bullet

Factors that Determine Treatment & Timing

bullet

Questions for your Doctor 

bullet

Treatment Decisions | Watch & Wait

bullet

Options at relapse?

bullet

Overview

bullet

Types - Overview

bullet

What's a drug?

 

Independent of Health Industry Funding - DEPENDENT on your support!

Dependent on public support!

 
Disclaimer:  The information on Lymphomation.org is not intended to be a substitute for 
professional medical advice or to replace your relationship with a physician.
For all medical concerns,  you should always consult your doctor. 
Patients Against Lymphoma, Copyright 2004,  All Rights Reserved.